Recent News for DOVA - Dova Pharmaceuticals, Inc.

Date Title
Oct 16 The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist
Oct 16 Analysis: Positioning to Benefit within Kopin, MDC Partners, Dova Pharmaceuticals, Revlon, Imprimis Pharmaceuticals, and Minerva Neurosciences — Research Highlights Growth, Revenue, and Consolidated Results
Oct 1 With an assist from Bausch Health, Dova to add 100 sales professionals to market gastro drug
Sep 27 CORRECTING and REPLACING – Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET® (Avatrombopag)
Sep 27 Dova Pharma to co-promote Doptelet in U.S. with Salix Pharma
Sep 27 Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET® (Avatrombopag)
Sep 26 Dova Pharmaceuticals to Present at Upcoming Investor Conferences
Sep 26 What Investors Should Know About Dova Pharmaceuticals Inc’s (NASDAQ:DOVA) Financial Strength
Sep 17 The Week Ahead: Alibaba Investor Day, FedEx Earnings, Eventbrite IPO
Sep 15 Stocks To Watch: Oracle Looks To Lift Tech Sector
Sep 11 Dova Pharmaceuticals to Host Investor & Analyst Day on September 20, 2018
Sep 4 Dova Pharma files U.S. marketing application for expanded use of Doptelet; shares up 1% after hours
Sep 4 Dova Pharmaceuticals Submits Supplemental New Drug Application for DOPTELET® (avatrombopag) for the Treatment of Chronic ITP
Sep 4 Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/04/2018)
Aug 29 Why Raymond James Is Bullish On Deciphera, Dova Pharmaceuticals
Aug 29 Benzinga's Top Upgrades, Downgrades For August 29, 2018
Aug 29 Premarket analyst action - healthcare
Aug 16 Analysis: Positioning to Benefit within Amtech, NL Industries, Dova Pharmaceuticals, Sientra, Dorian LPG, and Assembly Biosciences — Research Highlights Growth, Revenue, and Consolidated Results
Aug 15 Dova Pharma chief walks the walk with nearly $500K stock purchase
Aug 11 Dova Pharmaceuticals (DOVA) CEO Alex Sapir on Q2 2018 Results - Earnings Call Transcript
Aug 10 Some highs, lows as RTP biotech companies report earnings
Aug 9 Dova Pharmaceuticals: 2Q Earnings Snapshot
Aug 9 Dova Pharmaceuticals misses by $0.07, beats on revenue
Aug 9 Dova Pharmaceuticals Reports Second Quarter 2018 Operating and Financial Results
Aug 9 The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings
Back to the Main DOVA Page...